Cytokinetics to Participate in Upcoming Investor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cytokinetics to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK ) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present at the 28 th Annual Piper Jaffray Healthcare Conference on November 30, 2016 at 12:00 PM ET at the Lotte New York Palace Hotel in New York City. Members of Cytokinetics’ senior management team will also participate in the Citi Global Healthcare Conference on December 7, 2016 at the Lotte New York Palace Hotel.

Interested parties may access the live webcast of the Piper Jaffray presentation by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com . The webcast replay of the presentation will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of the event.

About Cytokinetics

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility. Cytokinetics’ lead drug candidate is  tirasemtiv , a fast skeletal muscle troponin activator, for the potential treatment of ALS.  Tirasemtiv  has been granted orphan drug designation and fast track status by the U.S. Food and Drug Administration and orphan medicinal product designation by the European Medicines Agency for the potential treatment of ALS. Cytokinetics retains the right to develop and commercialize  tirasemtiv , subject to an option held by Astellas Pharma Inc. Cytokinetics is also collaborating with Astellas to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy, chronic obstructive pulmonary disease and ALS. Cytokinetics is collaborating with Amgen Inc. to develop  omecamtiv mecarbil , a novel cardiac muscle activator, for the potential treatment of heart failure. Amgen holds an exclusive license worldwide to develop and commercialize  omecamtiv mecarbil  and Astellas holds an exclusive license worldwide to develop and commercialize CK-2127107. Both licenses are subject to Cytokinetics' specified development and commercialization participation rights. For additional information about Cytokinetics, visit  http://www.cytokinetics.com/ .

Contact: Cytokinetics Diane Weiser Vice President, Corporate Communications, Investor Relations (650) 624-3060

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 3

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 3

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 4

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 8

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 1

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading

Top 5 Most Recently Viewed Articles

Top AI Technology Stocks for Smart Investors in 2025

Updated Category News Views 466

The Emergence of AI in Technology Investments The rise of artificial intelligence is transforming how industries operate, paving the way for lucrative opportunities for savvy investors. As technology continues to evolve, several companies stand out as particularly well-positioned to capitalize on this AI boom in the coming years. In this article, we will explore three...

Continue Reading
Unlocking High Returns: Exploring the Power of Shareholder Yield

Updated Category News Views 28

Understanding High Dividends and the Importance of Yield When we encounter a stock with a high dividend yield, it often sparks our curiosity. An initial impulse might lead you to calculate potential returns from a sizable investment. What if you put $10,000 into a stock boasting a 9.3% yield? A tempting thought! However, prudent investors know that it’s essential to dig...

Continue Reading
Daqo New Energy Corp. Reports Impressive Q3 2025 Results

Updated Category News Views 160

Daqo New Energy's Financial Performance in Q3 2025 Daqo New Energy Corp. (NYSE: DQ) recently presented its unaudited financial results for the third quarter of 2025, highlighting significant achievements and operational optimizations amid a recovering market for solar photovoltaic (PV) technologies. Financial Highlights of Q3 2025 The company reported a total cash and...

Continue Reading
Off-Markt Launches Innovative Real Estate Social Platform

Updated Category News Views 107

Off-Markt: A New Way to See and Share Homes Off-Markt introduces a peer-to-peer social platform that reshapes how people discover, discuss, and decide on homes. Founded by entrepreneur Alison Bernstein, the platform gives every property space to share its own story—beyond square footage and specs. Instead of defaulting to traditional listings, Off-Markt builds a lively...

Continue Reading
Bitwarden Rolls Out Enhanced Native Mobile Apps for Users

Updated Category News Views 253

Bitwarden Launches Enhanced Mobile Applications Bitwarden, a recognized leader in password, secrets, and passkey management, has taken a significant step with the launch of its native mobile applications for iOS and Android. This rollout signifies a commitment to improving user experience dramatically while ensuring top-notch security for its users. A Revolution in Mobile...

Continue Reading